Galapagos to present at upcoming investor conferences
24 August 2022 - 10:01PM
Mechelen, Belgium; 24
August 2022,
22.01
CET; Galapagos NV (Euronext & NASDAQ:
GLPG) today announced that
management will participate in
the following upcoming investor
conferences:
- Citi’s 17th Annual Biopharma
Conference. September 8, 2022 in
Boston
- Morgan Stanley 20th
Global Healthcare Conference. September 12-14,
2022 in New York
- Bank of America Merrill Lynch Global Healthcare
Conference. September 15, 2022 in London
- KBC Securities
Virtual Life Sciences Conference.
September 16, 2022
- JP Morgan CEO
Call
Series. September 28, 2022
- Credit Suisse
31st Annual
Healthcare Conference. November 8-10, 2022 in
Rancho Palos Verdes, CA
- Bryan Garnier Virtual Conference on
Cell Therapy
Innovation. November 14, 2022
- Jefferies
2022 Global Healthcare
Conference. November 16-17, 2022 in London
- Kepler Cheuvreux
Virtual Life Science
Days. November 21, 2022
- Deutsche Bank 2022
Call
Series. November 30, 2022
Additional information regarding these events
will be available on the investor section of the Galapagos website
at glpg.com/events.
About
GalapagosGalapagos is a fully integrated biotechnology
company focused on discovering, developing, and commercializing
innovative medicines. We are committed to improving patients’ lives
worldwide by targeting diseases with high unmet needs. Our R&D
capabilities cover multiple drug modalities, including small
molecules and cell therapies. Our portfolio comprises discovery
through to Phase 3 programs in inflammation, oncology, fibrosis,
and other indications. Our first medicine for rheumatoid arthritis
and ulcerative colitis is approved and available in the European
Union (including Norway), Great Britain and Japan. For additional
information, please visit www.glpg.com or follow us on LinkedIn or
Twitter.
ContactInvestors:Sofie
Van GijselHead of Investor Relations+1 781 296 1143
Sandra CauwenberghsDirector Investor Relations+32 495 58 46
63ir@glpg.com
Media:Marieke VermeerschHead of Corporate
Communication+32 479 490 603media@glpg.com
Forward-looking statements
This release may contain forward-looking
statements. Such forward-looking statements are not guarantees of
future results. These forward-looking statements speak only as of
the date of publication of this document. Galapagos expressly
disclaims any obligation to update any forward-looking statements
in this document, unless specifically required by law or
regulation.
- Galapagos to present at upcoming investor conferences
Galapagos (EU:GLPG)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Galapagos (EU:GLPG)
Historical Stock Chart
Von Apr 2023 bis Apr 2024
